Mechanisms of change in extended cognitive behavioral treatment for tobacco dependence

Drug and Alcohol Dependence

Volumn 109, Issue 1-3, 2010, Pages 114-119

  Hendricks, Peter S ^a   Delucchi, Kevin L ^a   Hall, Sharon M ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Cessation; Mediation; Self efficacy; Smoking; Tobacco dependence; Treatment

Indexed keywords

AMFEBUTAMONE; NICOTINE GUM;

ADULT; AFFECT; ARTICLE; BEHAVIOR CHANGE; CLINICAL TRIAL; COGNITIVE THERAPY; CONTROLLED CLINICAL TRIAL; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MOTIVATION; NAMED INVENTORIES, QUESTIONNAIRES AND RATING SCALES; PARTNER INTERACTION QUESTIONNAIRE; PATIENT COUNSELING; PERCEIVED STRESS SCALE; PRIORITY JOURNAL; PROFILE OF MOOD STATES; RANDOMIZED CONTROLLED TRIAL; RELAPSE; SELF CONCEPT; SHORT FORM 36; SMOKING CESSATION; SOCIAL SUPPORT; THOUGHTS ABOUT ABSTINENCE QUESTIONNAIRE; TOBACCO DEPENDENCE;

ADULT; AFFECT; BUPROPION; CHEWING GUM; COGNITIVE THERAPY; DOPAMINE UPTAKE INHIBITORS; FEMALE; HUMANS; MALE; MIDDLE AGED; MOTIVATION; NICOTINE; NICOTINIC AGONISTS; PSYCHOMETRICS; RECURRENCE; SELF EFFICACY; SMOKING CESSATION; SOCIAL SUPPORT; STRESS, PSYCHOLOGICAL; TOBACCO USE DISORDER; TREATMENT OUTCOME;

NICOTIANA TABACUM;

EID: 77953026558     PISSN: 03768716     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.drugalcdep.2009.12.021     Document Type: Article

References (48)

1. Abrams D.B., Herzog T.A., Emmons K.A., Linnan L. Stages of change versus addiction: a replication and extension. Nicotine Tob. Res. 2000, 2:223-229.
2. Bandura A. Self-efficacy: toward a unifying theory of behavior change. Psychol. Rev. 1977, 84:191-215.
3. Bandura A. Self-Efficacy: The Exercise of Control 1997, Freeman, New York.
4. Brandon T.H., Vidrine J.I., Litvin E.B. Relapse and relapse prevention. Annu. Rev. Clin. Psychol. 2007, 3:257-284.
5. Brendryen H., Kraft P. Happy ending: a randomized controlled trial of a digital multi-media smoking cessation intervention. Addiction 2008, 103:478-484.
6. Cohen S., Kamarck T., Mermelstein R. A global measure of perceived stress. J. Health Soc. Behav. 1983, 24:385-396.
7. Cohen S., Lichtenstein E. Partner behaviors that support quitting smoking. J. Consult. Clin. Psychol. 1990, 58:304-309.
8. Danaher B.G., Smolkowski K., Seeley J.R., Severson H.H. Mediators of a successful web-based smokeless tobacco cessation program. Addiction 2008, 103:1706-1712.
9. Ferguson S.G., Shiffman S., Gwaltney C.J. Does reducing withdrawal severity mediate nicotine patch efficacy? A randomized clinical trial. J. Consult. Clin. Psychol. 2006, 74:1153-1161.
10. Fiore M.C., Bailey W.C., Cohen S.J., et al. Treating Tobacco Use and Dependence. Clinical Practice Guideline 2000, U.S. Department of Health and Human Services, Public Health Service, Rockville, MD.
11. Fiore M.C., Jaén C.R., Baker T.B., et al. Treating Tobacco Use and Dependence: 2008 update. Clinical Practice Guideline 2008, U.S. Department of Health and Human Services, Public Health Service, Rockville, MD.
12. Gwaltney C.J., Shiffman S., Balabanis M.H., Paty J.A. Dynamic self-efficacy and outcome expectancies: prediction of smoking lapse and relapse. J. Abnorm. Psychol. 2005, 114:661-675.
13. Gwaltney C.J., Shiffman S., Norman G.J., Paty J.A., Kassel J.D., Gnys M., Hickcox M., Waters A., Balabonis M. Does smoking abstinence self-efficacy vary across situations? Identifying context-specificity within the Relapse Situation Efficacy Questionnaire. J. Consult. Clin. Psychol. 2001, 69:516-527.
14. Gwaltney C.J., Shiffman S., Sayette M.A. Situational correlates of abstinence self-efficacy. J. Abnorm. Psychol. 2005, 114:649-660.
15. Hall S.M., Havassy B.E., Wasserman D.A. Commitment to abstinence and acute stress in relapse to alcohol, opiates, and nicotine. J. Consult. Clin. Psychol. 1990, 58:175-181.
16. Hall S.M., Humfleet G.L., Reus V.I., Muñoz R.F., Cullen J. Extended nortriptyline and psychological treatment for cigarette smoking. Am. J. Psychiatry 2004, 161:2100-2107.
17. Hall S.M., Humfleet G.L., Reus V., Muñoz R., Hartz D., Maude-Griffin R. Psychological intervention and antidepressant treatment in smoking cessation. Arch. Gen. Psychiatry 2002, 59:930-936.
18. Hall S.M., Humfleet G.L., Muñoz R.F., Reus V.I., Robbins J.A., Prochaska J.J. Extended treatment of older cigarette smokers. Addiction 2009, 104:1043-1052.
19. Hall S.M., Munoz R.F., Reus V.I. Cognitive-behavioral intervention increases abstinence rates for depressive-history smokers. J. Consult. Clin. Psychol. 1994, 62:141-146.
20. Hall S.M., Reus V.I., Muñoz R.F., Sees K.L., Humfleet G., Hartz D.T., Frederick S., Triffleman E. Nortriptyline and cognitive-behavioral therapy in the treatment of cigarette smoking. Arch. Gen. Psychiatry 1998, 55:683-690.
21. Hendricks P.S., Prochaska J.J., Humfleet G.L., Hall S.M. Evaluating the validities of different DSM-IV based conceptual constructs of tobacco dependence. Addiction 2008, 103:1215-1223.
22. Hurt R.D., Sachs D.P., Glover E.D., Offord K.P., Johnston J.A., Dale L.C., Khayrallah M.A., Schroeder D.R., Glover P.N., Sullivan C.R., Crognan I.T., Sullivan P.M. A comparison of sustained-release bupropion and placebo for smoking cessation. N. Engl. J. Med. 1997, 337:1195-1202.
23. Johansson P., Høglend P. Identifying mechanisms of change in psychotherapy: mediators of treatment outcome. Clin. Psychol. Psychother. 2007, 14:1-9.
24. Jorenby D.E., Leischow S.J., Nides M.A., Rennard S.I., Johnston J.A., Hughes A.R., Smith S.S., Muramoto M.L., Daughton D.M., Doan K., Fiore M.C., Baker T.B. A controlled trial of sustained-release bupropion, a nicotine patch, or both for smoking cessation. N. Engl. J. Med. 1999, 340:685-691.
25. Kazdin A.E. Mediators and mechanisms of change in psychotherapy research. Annu. Rev. Clin. Psychol. 2007, 3:1-27.
26. Koopman C., Gore-Felton C., Marouf F., Butler L.D., Field N., Gill M., Chen X.H., Israelski D., Spiegel D. Relationships of perceived stress to coping, attachment, and social support among HIV-positive persons. AIDS Care 2000, 12:663-672.
27. Lawhon D., Humfleet G.L., Hall S.M., Muñoz R.F., Reus V.I. Longitudinal analysis of abstinence-specific social support and smoking cessation. Health Psychol. 2009, 28:465-472.
28. Lerman C., Roth D., Kaufmann V., Audrain J., Hawk L., Liu A., Niaura R., Epstein L. Mediating mechanisms for the impact of bupropion in smoking cessation treatment. Drug Alcohol Depend. 2002, 67:219-223.
29. Litt M.D., Kadden R.M., Kabela-Cormier E., Petry N.M. Coping skills training and contingency management treatments for marijuana dependence: exploring mechanisms of behavior change. Addiction 2008, 103:638-648.
30. MacKinnon D.P., Lockwood C.M., Brown C.H., Wang W., Hoffman J.M. The intermediate endpoint effect in logistic and probit regression. Clin. Trials 2007, 4:499-513.
31. MacKinnon D.P., Lockwood C.M., Hoffman J.M., West S.G., Sheets V. A comparison of methods to test mediation and other intervening variable effects. Psychol. Methods 2002, 7:83-104.
32. Marlatt G.A., Gordon J.R. Relapse Prevention: Maintenance Strategies in the Treatment of Addictive Behaviors 1985, Guilford, New York.
33. McCarthy D.E., Piasecki T.M., Lawrence D.L., Jorenby D.E., Shiffman S., Baker T.B. Psychological mediators of bupropion sustained-release treatment for smoking cessation. Addiction 2008, 103:1521-1533.
34. McKay J.R. Is there a case for extended interventions for alcohol and drug use disorders?. Addiction 2005, 100:1594-1610.
35. McNair D.M., Lorr M., Droppleman L.F. Manual: Profile of Mood States (POMS). Revised 1992, Educational and Instructional Testing Service, San Diego, CA.
36. Muthén L.K., Muthén B.O. Mplus User's Guide 1998-2007, Muthén & Muthén, Los Angeles, CA. fifth edition.
37. Niaura R. Cognitive social learning and research perspectives on drug craving. Addiction 2000, 95:S155-S163.
38. Orleans C., Rimer B., Telepchak J., Fleisher L., Keintz M., Boyd N., et al. Clear Horizons: A Quit Smoking Guide for Smokers Aged 50 and Older 1997, Fox Chase Cancer Center, Philadelphia, PA.
39. Park E.W., Schultz J.K., Tudiver F.G., Campbell T., Becker L.A. Enhancing partner support to improve smoking cessation. Cochrane Database Syst. Rev. 2004, 3. CD002928. 10.1002/14651858.CD002928.pub2.
40. Piper M.E., Federman E.B., McCarthy D.E., Bolt D.M., Smith S.S., Fiore M.C., Baker M.B. Using mediational models to explore the nature of tobacco motivation and tobacco treatment effects. J. Abnorm. Psychol. 2008, 117:94-105.
41. Matching alcoholism treatment to client heterogeneity: post-treatment drinking outcomes. J. Stud. Alcohol. 1997, 58:7-29. Project MATCH Research Group.
42. Shiffman S., Balabanis M.H., Paty J.A., Engberg J., Gwaltney C.J., Liu K.S., Gnys M., Hickcox M., Paton S.M. Dynamic effects of self-efficacy on smoking lapse and relapse. Health Psychol. 2000, 19:315-323.
43. Shiffman S., Stone A.A., Hufford M.R. Ecological momentary assessment. Annu. Rev. Clin. Psychol. 2008, 4:1-32.
44. Sklar S.M., Annis H.M., Turner N.E. Group comparisons of coping self-efficacy between alcohol and cocaine abusers seeking treatment. Psychol. Addict. Behav. 1999, 13:123-133.
45. Vidrine D.J., Arduino R.C., Gritz E.R. Impact of a cell phone intervention on mediating mechanisms of smoking cessation in individuals living with HIV/AIDS. Nicotine Tob. Res. 2006, 8:S103-S108.
46. Ware J.E., Sherbourne C.D. The MOS 36-item Short-Form Health Survey (SF-36): I. Conceptual framework and item selection. Med. Care 1992, 30:473-483.
47. Witkiewitz K., Marlatt G.A. Relapse prevention for alcohol and drug problems: that was Zen, this is Tao. Am. Psychol. 2004, 59:224-235.
48. Witkiewitz K., Marlatt G.A. Why and how do substance abuse treatments work? Investigating mediated change. Addiction 2008, 103:649-650.